Multidrug Resistance Proteins in Renal Cell Carcinoma Cited by

Fol. Biol. 2008, 54, 187-192

https://doi.org/10.14712/fb2008054060187

Multidrug Resistance Proteins in Renal Cell Carcinoma

Ingrid Hodorová¹, S. Rybárová¹, P. Solár², J. Vecanová¹, J. Mihalik¹, P. Bohuš³, Y. Mellová⁴, D. Kluchová¹

¹Department of Anatomy, Faculty of Medicine, P. J. Šafárik University in Košice, Košice, Slovak Republic
²Department of Cell Biology, Faculty of Medicine, P. J. Šafárik University in Košice, Košice, Slovak Republic
³Department of Pathological Anatomy, Faculty of Medicine, P. J. Šafárik University in Košice, Košice, Slovak Republic
⁴Department of Anatomy, Jessenius Faculty of Medicine, Comenius University, Martin, Slovak Republic

Received August 2008
Accepted November 2008

Crossref Cited-by Linking

Yang Jian, Nagasawa Daniel T., Spasic Marko, Amolis Misha, Choy Winward, Garcia Heather M., Prins Robert M., Liau Linda M., Yang Isaac: Endogenous Vaults and Bioengineered Vault Nanoparticles for Treatment of Glioblastomas. Neurosurgery Clinics of North America 2012, 23, 451. <https://doi.org/10.1016/j.nec.2012.04.012>
Liu Qian, Zhang Hao, Smeester Lisa, Zou Fei, Kesic Matt, Jaspers Ilona, Pi Jingbo, Fry Rebecca C: The NRF2-mediated oxidative stress response pathway is associated with tumor cell resistance to arsenic trioxide across the NCI-60 panel. BMC Med Genomics 2010, 3. <https://doi.org/10.1186/1755-8794-3-37>
Ji Zhengang, Long Hua, Hu Yunsheng, Qiu Xiuchun, Chen Xiang, Li Zhao, Fan Degang, Ma Baoan, Fan Qingyu: Expression of MDR1, HIF-1\u03b1 and MRP1 in sacral chordoma and chordoma cell line CM-319. J Exp Clin Cancer Res 2010, 29. <https://doi.org/10.1186/1756-9966-29-158>